[JAMA] [补充材料]Adjuvant Nivolumab vs Observation in Resected Non–Small Cell Lung Cancer

 关闭 求助已关闭
thepowerful 发表于 2026-9-7 19:41:57 | 显示全部楼层 |阅读模式
悬赏30积分

期刊:JAMA

文献作者:Jamie E. Chaft; Zhuoxin Sun; Charles M. Rudin; Onkar V. Khullar; Charles B. Simone; Kurt Oettel; David Kozono; Rajitha Sunkara; Bryan Faller; James M. Isbell; Vladimir Hugec; Asheesh Shipstone; Eric C. McGary; Jeffrey M. Clarke; Ashita Talsania; Li Ding; Ramaswamy Govindan; Jacob M. Sands; John V. Heymach; Luis E. Raez; Shakun M. Malik; Thomas E. Stinchcombe; Sumithra J. Mandrekar; Jeffrey Bradley; David E. Gerber; Everett Vokes; David Gandara; Charles Staley; Suresh S. Ramalingam

出版日期:2026-8-11

DOI号:10.1001/jama.2026.8992

下载链接:https://jamanetwork.com/journals ... 785516181.77967.pdf

文献链接:https://doi.org/10.1001/jama.2026.8992

当前文献来源于 American Medical Association (AMA)


备注信息:至少应该包含protocol
全部回复0 显示全部楼层

发表回复

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

返回列表